GM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients With Breast Cancer

NCT06994507 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

352

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-induced Peripheral Neuropathy (CIPN)

Interventions

DRUG: GM1
DRUG: Placebo

Sponsor

Qilu Pharmaceutical Co., Ltd.